PhD-student, Physician
Karin Andersen
Department of Urology OUH Odense
| Projekt styring | ||
| Projekt status | Open | |
| Data indsamlingsdatoer | ||
| Start | - | |
| Slut | - | |
Uromune Vaccination For Complicated Reccurent Urinary Tract Infection: A Case Series
Short summary
Uromune is a mucosal immunotherapy indicated for the prevention of urinary tract infections (UTIs) caused by different pathogens. It is administered sublingually once a day for 3 months. Several studies have found a significant reduction in the frequency of recurrent UTIs but the UTIs were often uncomplicated or the test persons were healthy. Data is missing on whether the association is similar in comorbid patients with complicated treatment-resistant recurrent urinary tract infection.
Rationale
A (multicenter) case series including patients with treatment-resistant reccurent urinary tract infections. Uromune works by exposing the immune system to inactivated bacteria which aims to promote the production of specifics antibodies and bolster the overall immune response, thereby preventeing the colonization and infection of the urinary tract. The aim of the study is to investigate whether Uromune could be a possible treatment for comorbid patients with complicated treatment-resistant reccurent urinary tract infection
Description of the cohort
Patients with complicated treatment-resistant recurrent urinary tract infections. Incuded from Department of Urology OUH Odense (and AUH Aarhus).
Data and biological material
Urine samples. demografic data (age, sex), diagnosis (comorbidity), questionare data, date from the patient journal (duration and effect of treatment)